Finance News – Rsv
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Investors
Tariffs
Ceo
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Bse
Etf
Eth
Stablecoin
Investment
Blockchain
Ipo
Earnings
Index
Solana
Revenue
Sec
Trade
Inflation
Interest Rates
Token
Sensex
Wall Street
Coinbase
Treasury
Nasdaq
Federal Reserve
Nse
Traders
Bse Sensex
Nifty
China
Sp 500
Profit
Tesla
Gold
Investor
Company
Defi
Streamex
Attorney General
Cost Of Living Adjustment
Leasing Activity
Institutional Investing
Federal Energy Minister
House Democratic Staff
Mortgage Stress Tests
Sectoral Etfs
Dye Durham
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 26, 2025
RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants
The approval of Merck’s RSV vaccine by the restructured CDC panel could impact healthcare markets by potentially increasing infant vaccine adoption and influencing related pharmace...
Read Full Article →
CNBC Business • Jun 09, 2025
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →